Literature DB >> 20008596

Exposure to fifth disease in pregnancy.

Arthur Staroselsky1, Chagit Klieger-Grossmann, Facundo Garcia-Bournissen, Gideon Koren.   

Abstract

QUESTION: One of my pregnant patients came for a routine prenatal visit at 20 weeks' gestation. Near the end of the consultation, she asked me about "slapped cheek" disease and pregnancy, as her son had been diagnosed with fifth disease the previous week. What is the current guideline for pregnant women exposed to parvovirus B19? ANSWER: The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008596      PMCID: PMC2793222     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors.

Authors:  I P Jensen; P Thorsen; B Jeune; B R Møller; B F Vestergaard
Journal:  BJOG       Date:  2000-05       Impact factor: 6.531

3.  Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians.

Authors:  J F Rodis; A F Borgida; M Wilson; J F Egan; M V Leo; A O Odibo; W A Campbell
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

4.  Risk factors for parvovirus B19 infection in pregnancy.

Authors:  A K Valeur-Jensen; C B Pedersen; T Westergaard; I P Jensen; M Lebech; P K Andersen; P Aaby; B N Pedersen; M Melbye
Journal:  JAMA       Date:  1999 Mar 24-31       Impact factor: 56.272

5.  Hydrops fetalis secondary to parvovirus B19 infections.

Authors:  Jin Xu; Thomas C Raff; Nabil S Muallem; A George Neubert
Journal:  J Am Board Fam Pract       Date:  2003 Jan-Feb

6.  Feto-placentary pathology in human parvovirus B19 infection.

Authors:  A G Garcia; C S Pegado; R de C Cubel; M E Fonseca; I Sloboda; J P Nascimento
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1998 May-Jun       Impact factor: 1.846

7.  Parvovirus B19 infection in pregnancy.

Authors:  Joan Crane
Journal:  J Obstet Gynaecol Can       Date:  2002-09

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy.

Authors:  W C Koch; J H Harger; B Barnstein; S P Adler
Journal:  Pediatr Infect Dis J       Date:  1998-06       Impact factor: 2.129

Review 10.  Parvovirus B19 and the pathogenesis of anaemia.

Authors:  Hiroshi Chisaka; Eiji Morita; Nobuo Yaegashi; Kazuo Sugamura
Journal:  Rev Med Virol       Date:  2003 Nov-Dec       Impact factor: 6.989

View more
  2 in total

Review 1.  Evolutionary aspects of Parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development.

Authors:  Piyanki Das; Koustav Chatterjee; Nabanita Roy Chattopadhyay; Tathagata Choudhuri
Journal:  Virusdisease       Date:  2019-03-26

2.  Molecular screening of the human parvoviruses B19 and bocavirus 1 in the study of congenital diseases as applied to symptomatic pregnant women and children.

Authors:  Maria Belen Salbetti; Mauro Sebastian Pedranti; Paula Barbero; Paula Molisani; Martina Lazzari; Nicolas Olivera; Maria Beatriz Isa; Ariel Bertoldi; Laura Moreno; Maria Pilar Adamo
Journal:  Access Microbiol       Date:  2019-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.